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INTRODUCTION
Hematopoiesis in the developing murine embryo is char-
acterized by shifting of the major site of blood cell production
from one target organ to another. Primitive erythrocytes are
ﬁrst detectable in the fetal yolk sac (YS) blood islands on day
7.5 postcoitus (pc) [1]. Hematopoietic cells can be isolated
from the fetal liver (FL) on day 10 pc, and this organ becomes
the major site of blood cell production by day 12 pc [2,3]. The
bone marrow (BM) begins producing blood cells in the 4 days
before birth, and by 4 weeks of life becomes the main source
of hematopoietic cells for the young mouse [4].
The pattern of differentiation of hematopoietic cells at
each site of blood cell production during murine ontogeny
is restricted and unique. Under normal conditions in vivo,
YS hematopoietic cell production is limited to primitive
macrophages and erythrocytes [5]. In the FL, erythrocyte
production predominates with some granulocyte elements
detected [6,7]. In the BM, both erythroid and myeloid ele-
ments are present. These differences in cellular composition
of the hematopoietic sites may result from tissue- and stage-
specific interaction between hematopoietic stem cells
(HSCs) and the hematopoietic microenvironment.
To study the factors that regulate hematopoietic cell
proliferation and differentiation at various stages of ontoge-
ny, it is essential to isolate comparable populations of primi-
tive hematopoietic cells from the different target organs. A
variety of cell surface markers have been used to isolate
primitive HSCs possessing long-term repopulating ability.
Spangrude et al. [8] first characterized a population of
murine BM cells expressing stem cell antigen-1 (Sca-1), but
lacking the expression of the speciﬁc lineage markers CD4,
CD8, B220, Mac-1, and Gr-1. Randall et al. [9] have recent-
ly described populations of primitive hematopoietic cells
from adult BM and day 14.5 pc FL, which are characterized
by the expression of the cell surface markers Sca-1, c-kit,
and CD38 and lacks the expression of the specific lineage
markers CD3, CD4, CD5, CD8, B220, Mac-1, and Gr-1.
These stem cells provided reconstitution beyond 22–27
weeks when transplanted into adult conditioned mice [9].
Until recently, there has been doubt as to whether prim-
itive YS hematopoietic cells can contribute to definitive
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ABSTRACT
Murine fetal liver (FL) and adult bone marrow (BM) hematopoietic stem cells (HSCs) are characterized by cell sur-
face expression of CD38 and c-kit. Because murine yolk sac (YS) HSC activity precedes the initiation of FL hemato-
poiesis, we investigated whether YS-derived HSCs also expressed c-kit and CD38. c-KitCD38lineage cells
derived from day 9 YS as well as adult BM were found to be enriched in high proliferative potential colony-forming
cells. c-KitCD38lineage YS or adult BM cells were capable of long-term reconstitution (6 months) of busul-
fan-conditioned newborn or lethally irradiated adult mice, respectively. In contrast, c-kitCD38lineage popula-
tions from both tissues were enriched in lineage-committed progenitors and had no long-term HSC activity. We
concluded that c-kit and CD38 are cell surface markers of HSCs expressed throughout murine ontogeny. 
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hematopoiesis. When using an adult mouse as a conditioned
recipient, the HSC marrow reconstitution potential cannot
be detected in the YS until day 11 pc [10]. However, when
transplanted into conditioned newborn recipients, hemato-
poietic cells with long-term repopulating ability can be
detected at day 9 or 10 pc [11–13].
Expression of HSC-associated markers (described above
for BM and FL cells) in day 9 YS cells is variable. The cell
surface expression of CD34, CD44, c-kit, and CD38 on day
9 YS cells have recently been described [13]. In these stud-
ies, no functional properties of cells expressing both c-kit
and CD38 were examined. Moreover, expression of Sca-1
on these cells was undetectable. Because c-kit and CD38 are
expressed by adult BM and FL HSCs [9], we sought to
determine if HSC activity can be detected within the c-
kitCD38 population of day 9 YS cells. Such a finding
would suggest c-kit and CD38 as markers of HSCs through-
out murine ontogeny.
MATERIALS AND METHODS
Cell preparation
Embryos were obtained and YSs isolated as described
previously [14]. Dissected YSs were incubated with 0.1%
collagenase (Sigma, St. Louis, MO) in 20% fetal calf serum
(FCS) for 30 minutes at 37C, and dispersed YS cells were
drawn through a 23-gauge needle, deposited into a poly-
styrene tube, and pelleted at 500g for 10 minutes. BM
mononuclear cells were obtained from adult mice using
standard methods [15]. The cell suspensions were counted
using a Coulter counter (Coulter, Miami, FL). The care and
use of animals in these studies was approved by the Indiana
University School of Medicine Institutional Animal Care
and Use Committee.
FACS analysis and cell sorting
Pelleted cells were first labeled with CD16/CD32 to
block Fc receptors on hematopoietic cells. They were then
incubated with phycoerythrin (PE)-conjugated c-kit, fluo-
rescein isothiocyanate (FITC)-conjugated TER-119 (for YS
cells), FITC-conjugated CD4, CD8, Mac-1, Gr-1, and
B220 (for BM cells), and biotin-conjugated CD38 followed
by streptavidin-conjugated allophycocyanin (APC)
(Pharmingen, San Diego, CA). All incubations were per-
formed on ice for 15 minutes per labeling step, and cells
were washed with phosphate-buffered saline (PBS) plus 2%
FCS between steps. Appropriate isotype control samples as
previously described were also prepared [12]. Labeled cells
were resuspended in Iscove’s modiﬁed Dulbecco’s medium
(IMDM) with 10% FCS and specific populations of cells
were isolated using a FACStarplus (Becton Dickinson
Immunocytometry Systems, San Jose, CA). Isolated popula-
tions were then used in high proliferative potential colony-
forming cell (HPP-CFC) and transplantation assays.
HPP-CFC assay
Double-layer agar cultures were prepared as previously
described [16]. Recombinant hematopoietic growth factors
including human macrophage colony-stimulating factor-1
([M-CSF] 1600 U; Genetics Institute, Camden, MA), murine
interleukin-3 ([IL-3] 200 U), murine IL-1a (500 U), and rat
SCF (100 ng; PeproTech, Rocky Hill, NJ) were used in a ﬁnal
volume of 1.5 mL. Fractionated and unfractionated YS or BM
cells were plated in triplicate and incubated in a 5% O2, 10%
CO2, and 85% N2 humidiﬁed environment. On day 14 of cul-
ture, colonies 0.5 mm were scored as HPP-CFCs. Colonies
0.5 mm were recorded as low proliferative potential colony-
forming cells (LPP-CFCs).
Transplantation assay
Adult congenic C57BL/6J glucose phosphate iso-
merase-1b (Gpi-1b/Gpi-1b) mice were conditioned with a
total of 1100 cGy administered in two doses as described
[13]. c-KitCD38lineage and c-kitCD38lineage cells
(200) from Gpi-1a/Gpi-1a (GPI-1A) donor BM-derived and
2105 low-density GPI-1B BM-derived competitor mononu-
clear cells were injected per recipient via tail-vein injection.
Pregnant GPI-1A dams were injected subcutaneously with 15
mg/kg of busulfan on day 18 pc. Newborn mice were injected
with 200 c-kitCD38TER-119/FcGPI-1B and c-
kitCD38TER-ll9/FcGPI-1B donor YS-derived and
2105 low-density GPI-1A BM-derived competitor mononu-
clear cells per recipient via intrahepatic injection on day 1 of
life. Recipient animals were bled from the tail vein on a
monthly basis after transplant for analysis of donor red and
white blood cell GPI-1 isoenzyme chimerism. 
Isolation of peripheral blood lymphocytes and granulocytes
B and T lymphocytes and granulocytes were isolated
from the white blood cell buffy coat using a magnetic sepa-
ration column (Miltenyi Biotec, Sunnyvale, CA) as previous-
ly described [11].
GPI-1 assay
Isolated red blood cells, B and T lymphocytes, and
granulocytes were deposited in separate microcentrifuge
tubes and lysed by freeze-thawing in distilled water. The cell
lysates were applied to Titan III Zip Zone cellulose acetate
plates (Helena Laboratories, Beaumont, TX) using a Super
Z 0.5 L 8-well applicator (Helena Laboratories). Loaded
gels were run for 30 minutes in an electrophoresis chamber
at 300 V. The GPI-1 isoenzymes were detected as has been
described [17].
RESULTS
Using ﬂow cytometry, we ﬁrst examined lineage-nega-
tive adult BM and day 9 YS hematopoietic cells for expres-
sion of c-kit. Only 1–2% of adult BM cells lacking the
expression of the speciﬁc lineage markers CD4, CD8, B220,
Mac-1, and Gr-1 were c-kit. Similarly, 1–2% of YS cells
were c-kit while lacking expression of the speciﬁc erythroid
marker TER-119. We then examined BM and YS c-kitlin-
eage populations for expression of the membrane glyco-
protein CD38. Only 10 	 5% of c-kitlineage BM cells
expressed CD38, whereas most (86 	 12%) of the c-kitlin-
eage YS cells exhibited CD38 expression, many of them
CD38 bright (Figure 1).
Unfractionated and fractionated populations of c-
kitCD38lineage or c-kitCD38lineage adult BM or
day 9 YS cells were plated in an HPP-CFC assay to examine
in vitro enrichment for primitive hematopoietic cells.
HSC Activity in c-KitCD38 YS Cells
71B B & M T
Unfractionated YS cells were threefold enriched in HPP-
CFC compared with unfractionated BM cells (Table 1).
Both YS- and BM-derived c-kitCD38lineage popula-
tions were enriched in HPP-CFC compared with c-
kitCD38lineage cells (Table 1). c-KitCD38lineage
BM cells were 600-fold enriched for HPP-CFC compared
with unfractionated BM cells, and their YS-derived counter-
parts were 200-fold enriched for HPP-CFC compared with
unfractionated cells. c-KitCD38lineage BM and YS cell
populations produced substantial numbers of LPP-CFC,
possibly reflecting enrichment for more committed pro-
genitors (Table 1).
In vivo transplantation experiments were conducted to
examine c-kitCD38lineage and c-kitCD38lineage
populations of BM and day 9 YS cells for HSC activity.
Adult BM-derived cell populations were transplanted into
adult recipients, and YS-derived cells were transplanted into
newborn mice because day 9 YS cells do not engraft in adult
animals [11]. 
Peripheral blood was analyzed for donor cell chimerism
on a monthly basis after transplant. Partial short-term repop-
ulating ability was found in the c-kitCD38lineage popu-
lations of BM and YS cells with 46% and 18%, respectively,
mean donor chimerism at 2 months posttransplant (Figure
2). However, more sustained long-term repopulating activity
was detected in the c-kitCD38lineage YS and BM popu-
lations (Figure 2). Table 2 shows the percent donor red cell
chimerism for individual YS and BM recipients analyzed at 6
Figure 1. FACS analysis
(A) Bone marrow cells gated in the upper left corner (R2) represent c-kitlineage cells, which were then examined for CD38 expression (M1). (B) Day 9 pc yolk
sac cells gated in the upper left corner (R2) represent c-kitTER-119/Fc cells, which were then examined for CD38 expression (M1). APC, allophycocyanin;
FITC, ﬂuorescein isothiocyanate; Lin, lineage.
Table 1. HPP-CFC assay of unfractionated and fractionated BM and day 9 pc YS cells
Fractionated cellsb
Unfractionated cellsa c-kitCD38lineage c-kitCD38lineage
Colony type (n2) YS BM BM YS BM YS
HPP 174  35 51  14 373  75 362  45 53  11 25  11
LPP 1200  110 800  50 166  75 30  15 773  46 194  21
aMean colonies 	 SD per 100,000 cells plated.
bMean colonies 	 SD per 1000 cells plated.
BM, bone marrow; HPP, high proliferative potential; LPP, low proliferative potential; YS, yolk sac.
A
B
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months posttransplant. Individual white blood cell lineage
reconstitution for c-kitCD38lineage YS and BM trans-
plant recipients analyzed at 6 months posttransplant is shown
in Table 3. At 6 months posttransplant, individual white
blood cell lineage engraftment was comparable with red
blood cell donor reconstitution for YS and BM c-
kitCD38lineage transplanted populations.
DISCUSSION
In this report, we demonstrated that HSC activity is
present in day 9 YS hematopoietic cells expressing the cell
surface markers c-kit and CD38. Our findings confirmed
those of Randall et al. [9], who described HSC activity in c-
kitCD38 adult BM, and extended their ﬁndings regarding
murine BM and FL to the YS, one of the first sites of
hematopoiesis during murine ontogeny.
Randall et al. [9] had separated Sca-1c-kitlineage
adult BM cells into CD38high and CD38low/ populations
and found no long-term reconstituting ability in the
CD38low/ group. We therefore decided to separate c-
kitlineage BM cells into two groups: CD38 and CD38.
We found that only 10% of c-kitlineage BM cells
expressed CD38. With YS c-kitlineagecells, a large pro-
portion expressed CD38, and again these cells were sub-
divided into CD38 or CD38 groups.
It is intriguing that 86 	 12% of c-kitlineage day 9
YS cells expressed CD38 (Figure 1). As a membrane glyco-
protein found on early B-cell and T-cell precursors, CD38
expression has been linked to B-cell proliferation and calci-
um mobilization [18–20]. 
Triggering of human CD38 induces T-cell and natural
killer-cell proliferation [21–22]. Therefore, it is possible that
expression of CD38 as a proliferation-associated marker
may extend to more primitive cells early in ontogeny,
including day 9 YS cells. 
CD38 has been shown to mediate lymphocyte binding
to endothelial cells, suggesting a possible role as an adhesion
molecule [23]. Recently, the murine monoclonal antibody
(mAb) Moon-1 has been shown to inhibit CD38-mediated
adhesion [24]. The human CD38 ligand recognized by
Moon-1 has been shown to correspond to PECAM-1, an
adhesion molecule expressed by endothelial cells [25]. These
findings, coupled with the observation of HSC activity in
CD38 populations of murine adult BM, FL, and YS
hematopoietic cells, suggest a possible role for CD38 in
homing. However, it is important to note that in human
BM, HSC activity is found within the CD38 population of
hematopoietic cells [26].
The double layer agar system provides an in vitro clonal
measurement of primitive hematopoietic cells (HPP-CFCs)
and more committed progenitor cell populations (LPP-
CFCs) [27]. HPP-CFCs are defined by an ability to form
colonies 0.5 mm in diameter, typically containing 50,000 or
more cells per colony. HPP-CFCs are characterized by their
multipotential ability, requirement for multiple growth fac-
tors for colony formation, and relative resistance to cytotoxic
drug treatment. They are closely related, but not identical, to
primitive stem cells with long-term reconstituting ability
[28,29]. LPP-CFC colonies are 0.5 mm in diameter and
contain cells responsive to single-growth factors [27]. Our
data demonstrating enrichment of c-kitCD38lineage BM
Figure 2. Sequential analysis of donor BM and YS repopulation of host circulating cells
(A) Mean percent red cell donor chimerism at monthly intervals for c-kitCD38lineage and c-kitCD38lineage BM cells transplanted into adult recipients.
(B) Mean percent red cell donor chimerism at monthly intervals after transplant of c-kitCD38TER-199/Fc and c-kitCD38TER-199/Fc YS cells into
newborn recipients.
Table 2. Percent red cell donor chimerism for each murine recipient at 6
months posttransplant
c-kitCD38lineage c-kitCD38lineage
Mouse YS BM YS BM
1 40 100 0 0
2 40 50 0 0
3 45 50 0 0
4 40 4 0 0
5 40 NAa 0 0
aMouse died of meningitis at 3.5 weeks posttransplant with no evidence of donor red
cell engraftment. 
NA, not available.
A B
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and YS cells for HPP-CFC correlated with our in vivo trans-
plantation findings of long-term reconstitution of condi-
tioned recipients (Table 1). Our observation of partial short-
term reconstitution of c-kitCD38lineage transplanted
recipients of YS or BM cells may be explained by enrichment
for committed progenitors in this population, as evidenced
by our LPP-CFC results (Table 1).
In the first 5 months after transplantation, significant
variability was noted in the percent donor chimerism
between recipient mice transplanted with YS or adult BM
donor cells (Figure 2). At 6 months, this variability persisted
within the adult BM donor cell group (mean 40 	 25), but
not within the YS donor cell group (Table 2). The explana-
tion may lie in the different methods of cell administration
and the low numbers of cells transplanted. Adult BM donor
cells were injected into adult recipients via tail-vein injec-
tion, whereas YS cells were injected into newborn mice via
an intrahepatic route. Intrahepatic injection of donor cells in
newborn mice may have resulted in more uniform seeding
of the initial target organ (the FL in this case) as opposed to
the situation in adult recipients in which intravenously
injected cells must home to the BM before the establish-
ment of donor-derived hematopoiesis. In addition to differ-
ences in seeding efficiency, the relatively high percent of
reconstitution obtained by Randall et al. [9] with Sca-1c-
kitCD38lineage BM cells may reflect the isolation of a
relatively purer population compared with our c-
kitCD38lineage BM cells.
To compare the competitive repopulating ability of c-
kitCD38lineage YS- and adult BM-derived populations,
it was necessary to establish a transplantation model in which
donor cells were injected into recipients with similar hemato-
poietic compartments. Because day 9 YS cells do not engraft
adult recipients, it was necessary to compare engraftment of
YS-derived and adult BM-derived c-kitCD38lineage
donor cells transplanted into newborn recipients. Adult BM
cells had previously been demonstrated to engraft in new-
born mice [17]. With 200 donor c-kitCD38lineage BM
and 2105 low-density mononuclear competitor BM cells
per newborn recipient, we found no evidence of donor cell
engraftment in eight mice studied for 5 months after trans-
plant (unpublished data, M.C.Y.). Because the sorted cells
gave rise to the expected numbers of HPP-CFCs and LPP-
CFCs, we excluded any technical problems encountered in
isolating or handling the sorted cells. In contrast, newborn
recipients of 200 c-kitCD38lineage YS cells and 2105
low-density mononuclear cells were found to have 40% of
peripheral blood cells of donor origin. Although we were
unable to quantitatively compare BM and YS donor cell c-
kitCD38lineage competitive repopulating abilities, we
concluded that YS-derived cells may have greater competi-
tive repopulating ability than their BM-derived counterparts
in the newborn.
In addition to YS, FL, and BM, the para-aortic
splanchnopleure (P-Sp) region of the day 9 embryo had
been shown to produce deﬁnitive HSCs [30]. We recently
reported equivalent long-term blood cell lineage repopula-
tion of conditioned newborn recipients using day 9 P-Sp or
YS c-kitCD34 donor cells, suggesting a model by which
HSCs from each site colonize the FL [13]. In preliminary
experiments, 15% of day 9 pc P-Sp cells were found to
express c-kit and CD38 (unpublished data, M.C.Y.). Evalua-
tion of this population for in vitro primitive hematopoietic
cell enrichment and in vivo HSC activity is warranted.
In conclusion, we have demonstrated HSC activity in
day 9 YS cells characterized by cell surface expression of c-
kit and CD38. There is now sufficient evidence to suggest
c-kit and CD38 as cell surface markers for HSC popula-
tions throughout murine ontogeny. We now have a
method for isolating comparable populations of primitive
hematopoietic cells from different target organs during
murine development.
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